Chapter 457 - 269: Highest Praise: A Young Leader of the Medical and Health Cause
Chapter 457: Chapter 269: Highest Praise: A Young Leader of the Medical and Health Cause
The feed from the Eastern Region was magnified on the main screen. Everyone’s attention turned to Wu Ting’s surgical video, eager to see what it contained.
The presentation in the surgical video began.
It started with an analysis of Lou Musaang’s condition and the thought process behind the surgical plan.
Many of the doctors present were already familiar with this case; in fact, there had been plans to hold a discussion about it during this very national skills competition.
Among the judges, Scholar Jiang vaguely recalled the patient. It was a friend of Wu Ting’s, and Wu Ting had even consulted him about the case.
At the time, Scholar Jiang had offered some suggestions, but the entire procedure was constrained by the available equipment and technology, making a perfect solution impossible to find.
Scholar Jiang had assumed the procedure would, at most, only complete the first phase: the vascular stent implantation.
However, to everyone’s surprise, after explaining the first stage of Lou Musaang’s operation, Wu Ting moved directly on to introducing the second stage.
As the video continued to play, everyone was left dumbfounded.
"Brand-new materials, a completely new system algorithm, and the application of a new, adjustable delivery system!"
Scholar Jiang himself was leading a key national research project for the "14th Five-Year Plan": *The Application of Hybrid Technology in Cardiovascular Surgery*.
The so-called Hybrid Technology is, to put it simply, a type of "hybrid surgery"—a recombination of multidisciplinary techniques.
This technology, first, requires the combined use of traditional open surgery and interventional methods to treat a lesion, or to separately treat lesions in different areas. The two approaches are complementary, aiming for the best possible outcome.
Second, the traditional surgical method does not directly address the lesion. Instead, it serves as an auxiliary measure, creating a more convenient and viable path for the interventional procedure. The lesion is ultimately treated directly using interventional techniques and devices.
The Fuwai team was currently researching a new method for treating multivessel disease: combining the surgical procedure of a minimally invasive coronary artery bypass with coronary intervention techniques.
The scope of this Surgical Technique was, in fact, quite broad. It encompassed many cardiovascular diseases, including aortic and coronary artery pathologies.
Wu Ting’s new, adjustable delivery system gave Scholar Jiang a vast space for imagination, sparking numerous new ideas and inspirations.
Watching Wu Ting’s surgical presentation, Scholar Jiang saw much more than just his clinical skill as a surgeon.
’Wu Ting truly is a rare, all-around talent.’
An idea began to form in Scholar Jiang’s mind.
"Old Yu, all you directors, this Director Wu... he’s truly a young man with a limitless future."
"Beyond his technical skill, he’s also the leader of a research team, the driving force behind a research project, a successful businessman, and an excellent social activist... We see a few pure surgeons, a few brilliant clinical geniuses, every year. But someone like Director Wu, with such comprehensive abilities, is truly a rare find."
"After taking on Lou Musaang’s case, he managed to solve the problems for both the first and second stages. He collaborated with an outstanding domestic enterprise in materials science, integrated cutting-edge algorithms from computer science, proactively partnered with local universities, and on top of that, he leads a local pharmaceutical company with its own R&D..."
"This Wu Ting... he reminds me of the founders, leaders, and pioneers of our teachers’ generation, the ones who built the medical field in the New Jin Country."
"Recently, this Director Wu has also been making waves internationally in the field of Hepatic Tumor Surgery. His personal fame and influence are unparalleled among the younger generation of doctors in our medical system."
"And now, in this national skills competition for heart surgery, he’s given me hope that we can conquer the national 14th Five-Year Plan project, *The Application of Hybrid Technology in Cardiovascular Surgery*. Watching his competition video... his clinical reasoning, his personal surgical skills, his leadership, his ability to integrate and apply knowledge from both within and outside his discipline... he is outstanding among his peers."
The more Scholar Jiang saw of Wu Ting’s performance, the more impressed and excited he became, and he gave him his utmost support and endorsement right then and there.
"Therefore, I believe Wu Ting receiving a perfect score is absolutely well-deserved!"
"In fact, Wu Ting’s inclusion in the final list of twelve is an affirmation of the competition itself. Although the final round hasn’t even happened yet, I’m already looking forward to Director Wu joining my research group for *The Application of Hybrid Technology in Cardiovascular Surgery*."
Scholar Jiang’s assessment was, in effect, a comprehensive affirmation and endorsement of Wu Ting.
After Scholar Jiang finished speaking, the other directors mulled it over and found themselves in deep agreement with his views.
The surgery itself showcased Wu Ting’s solid fundamentals, perfect teamwork, and standardized procedures. But more importantly, it presented a complete, systematic solution for aortic valve replacement in cases of complex cardiovascular malformation, complete with supporting software and hardware.
The fourth-generation absorbable polymer vascular stent was already being rolled out for clinical use in the heart surgery departments of many of Jin Country’s top hospitals.
They never expected Wu Ting to deliver an even bigger surprise!
A longer-term hope sparked in the minds of Scholar Jiang and the other directors: was it possible that, based on Wu Ting’s new therapy, they could finally establish an expert consensus—and perhaps even clinical guidelines—for Hybrid Technology in cardiovascular surgery that belonged uniquely to Jin Country Heart Surgery!